| abstract |
(57) [Summary]nOptionally, with one or more carriers, excipients, adjuvants, and / or diluents, the therapeutically effective ratio of formononetin to the isoflavone is in the range of 15: 1 to 2: 1; And / or a composition comprising one or more isoflavones selected from biochanin, genistein and daidzein. Formononetin and one or more isoflavones selected from biochanin, genistein and daidzein, optionally, one or more carriers, excipients in a ratio of formononetin to the isoflavone of 15: 1 to 2: 1 with therapeutic effect Compositions that may be included with agents, adjuvants and / or diluents are described. It also contains such a composition and prevents and / or treats circulatory diseases, improves blood lipoprotein levels, or reduces the risk of vascular disease, or reduces the risk of ischemic heart disease, arteriosclerosis A method for improving or maintaining bone density, such as reducing the risk of osteoporosis and / or preventing and / or treating bone fractures, will be described. |